112 related articles for article (PubMed ID: 2850215)
1. A tumor necrosis factor binding protein is present in human biological fluids.
Peetre C; Thysell H; Grubb A; Olsson I
Eur J Haematol; 1988 Nov; 41(5):414-9. PubMed ID: 2850215
[TBL] [Abstract][Full Text] [Related]
2. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.
Lantz M; Gullberg U; Nilsson E; Olsson I
J Clin Invest; 1990 Nov; 86(5):1396-1402. PubMed ID: 2173717
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of a tumor necrosis factor binding protein from urine.
Olsson I; Lantz M; Nilsson E; Peetre C; Thysell H; Grubb A; Adolf G
Eur J Haematol; 1989 Mar; 42(3):270-5. PubMed ID: 2924890
[TBL] [Abstract][Full Text] [Related]
4. A 63 kDa tumor necrosis factor inhibitor released from a human monocytic leukemia cell line, THP-1.
Aso H; Yoshite O; Tomioka Y; Rose MT; Mizugaki M
Microbiol Immunol; 1999; 43(1):53-9. PubMed ID: 10100747
[TBL] [Abstract][Full Text] [Related]
5. Efficient purification of recombinant human tumor necrosis factor beta from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors.
Schoenfeld HJ; Poeschl B; Frey JR; Loetscher H; Hunziker W; Lustig A; Zulauf M
J Biol Chem; 1991 Feb; 266(6):3863-9. PubMed ID: 1847389
[TBL] [Abstract][Full Text] [Related]
6. Solubilization of human placental tumor necrosis factor receptors as a complex with a guanine nucleotide-binding protein.
Hayakawa M; Hori T; Shibamoto S; Tsujimoto M; Oku N; Ito F
Arch Biochem Biophys; 1991 May; 286(2):323-9. PubMed ID: 1654785
[TBL] [Abstract][Full Text] [Related]
7. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.
Engelmann H; Aderka D; Rubinstein M; Rotman D; Wallach D
J Biol Chem; 1989 Jul; 264(20):11974-80. PubMed ID: 2545693
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
Andrews JS; Berger AE; Ware CF
J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
[TBL] [Abstract][Full Text] [Related]
9. TNF inhibitor with a low molecular weight found in the human sera.
Shimoda A; Hanaumi K; Kumagai K
Tohoku J Exp Med; 1995 Dec; 177(4):327-35. PubMed ID: 8928192
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia.
Buck C; Digel W; Schöniger W; Stefanic M; Ragnavachar A; Heimpel H; Porzsolt F
Leukemia; 1990 Jun; 4(6):431-4. PubMed ID: 2162999
[TBL] [Abstract][Full Text] [Related]
11. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity.
Loetscher H; Gentz R; Zulauf M; Lustig A; Tabuchi H; Schlaeger EJ; Brockhaus M; Gallati H; Manneberg M; Lesslauer W
J Biol Chem; 1991 Sep; 266(27):18324-9. PubMed ID: 1655744
[TBL] [Abstract][Full Text] [Related]
12. Synergistic growth-inhibitory activity of tumour necrosis factor and alpha interferon. Contribution to the monocyte-derived cytostatic activity towards human leukaemia K562 cells.
Nissen-Meyer J; Austgulen R; Espevik T
Scand J Immunol; 1988 Nov; 28(5):627-37. PubMed ID: 3212388
[TBL] [Abstract][Full Text] [Related]
13. Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors.
Yoshie O; Tada K; Ishida N
J Biochem; 1986 Sep; 100(3):531-41. PubMed ID: 3023310
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation.
Pennica D; Kohr WJ; Fendly BM; Shire SJ; Raab HE; Borchardt PE; Lewis M; Goeddel DV
Biochemistry; 1992 Feb; 31(4):1134-41. PubMed ID: 1310420
[TBL] [Abstract][Full Text] [Related]
15. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.
Engelmann H; Novick D; Wallach D
J Biol Chem; 1990 Jan; 265(3):1531-6. PubMed ID: 2153136
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new receptor subtype for tumor necrosis factor-alpha.
Schwalb DM; Han HM; Marino M; Warren R; Porter A; Goh C; Fair WR; Donner DB
J Biol Chem; 1993 May; 268(14):9949-52. PubMed ID: 7683686
[TBL] [Abstract][Full Text] [Related]
17. Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors.
Smith RA; Kirstein M; Fiers W; Baglioni C
J Biol Chem; 1986 Nov; 261(32):14871-4. PubMed ID: 3021754
[TBL] [Abstract][Full Text] [Related]
18. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor.
Seckinger P; Isaaz S; Dayer JM
J Biol Chem; 1989 Jul; 264(20):11966-73. PubMed ID: 2545692
[TBL] [Abstract][Full Text] [Related]
19. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.
Lantz M; Thysell H; Nilsson E; Olsson I
J Clin Invest; 1991 Dec; 88(6):2026-31. PubMed ID: 1752960
[TBL] [Abstract][Full Text] [Related]
20. Purification of type I and type II tumor necrosis factor receptors from human lung tissue.
Abdolrasulnia R; Shepherd VL
Am J Respir Cell Mol Biol; 1992 Jul; 7(1):42-8. PubMed ID: 1320902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
